Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF - Wikidata - awgldk - TriplyDB

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

http://www.wikidata.org/entity/Q34039426

about

Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery.Pretargeted molecular imaging and radioimmunotherapy.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Pretargeted Imaging and Therapy.

P2860

Q27026010-7D4054B3-8B9C-4BE8-84EA-F12968B961B5 Q33877207-7781F71C-DAF0-47FC-B651-C1D3BBFB22D8 Q35794797-EA981DB6-FD21-4F71-AD71-9E81A9B6F44A Q36395999-9561CF8C-51AC-4C91-BB9B-690F4ED91668 Q37233043-569E0FA3-F5F7-4367-B247-730D031CE556 Q38022016-87327E5F-E668-4BF1-B957-08CBCF24AEEB Q38206206-095A1196-CB65-40D8-A55F-796B7928F6B5 Q39421977-1DCEAEE5-8548-41B8-AC72-8D4E01DD4CC0

P2860

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

http://www.wikidata.org/entity/Q34039426

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@ast

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@en

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@nl

type

label

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@ast

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@en

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@nl

prefLabel

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@ast

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@en

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@nl

P1433

Q34039426-3359F254-6602-4740-8D22-ABCEC3E7655D

P1476

Q34039426-0915E899-D2C4-4C84-B474-063840006449

P2093

Q34039426-47EB4267-1619-4B92-9E1E-E67F24DAFE2A

Q34039426-4CD401D3-8F0E-440B-BF2C-F587DCB2B7BC

Q34039426-7CDE2248-A3B5-4B5A-8DB0-7BF4334AE665

Q34039426-896F3E10-35A3-4AD9-B065-F8BA4E5522E6

Q34039426-A2A69FF4-6455-4CB2-9585-FDF5A51B823B

Q34039426-EEBF9B9C-0F98-44FD-9916-AE3B4821C80C

Q34039426-F5E89DAC-A4DD-48F2-9D26-951FB2B873D9

P2860

Q34039426-0C80642A-A901-4F68-AE73-201CE9CCD14C

Q34039426-1BB08672-7E6D-4DA4-ADD2-A3332E02B384

Q34039426-1BB30711-627E-49AB-B69C-C5EF37B7A613

Q34039426-23111305-5FEE-4D56-893D-8C8E2D054F71

Q34039426-23C90B9C-8780-473B-9475-A1D46BAC4993

Q34039426-43961C91-79A9-45A2-9D56-7B4AC55DBFBB

Q34039426-4A7299EE-C2B2-4892-BC66-36E167628620

Q34039426-4CDA9DC7-8A58-4BDE-ABE9-B1CCFE0B0C49

Q34039426-6C8184D0-3750-4882-9D94-EFBFF0E23076

Q34039426-7166CE6E-2B6C-4CF1-899F-583696C900D8

P304

Q34039426-8F40E37F-6894-4776-9CED-E9825EC19189

P31

Q34039426-B49F018A-CFCC-4921-9D3A-324D742ED4A4

P356

Q34039426-D7C8ED61-ECD0-4237-B551-F9D9A33DE08A

P407

Q34039426-8E1BE3FA-7FBB-4C07-99FB-81810719B179

P433

Q34039426-66AEA435-3B7B-479A-8140-8D0A76C414D2

P478

Q34039426-6B68C28A-386F-4BA5-814E-DD5180787B48

P577

Q34039426-425D2507-C6A5-4BE1-B68C-6DABB670A695

P5875

Q34039426-32D27161-F91D-4BAB-9ABD-12130A9D9037

P698

Q34039426-E3A853FA-0027-4EE6-B169-FFB554AE02B6

P932

Q34039426-A96AC400-94F5-4C53-A674-07A24C0FEE57

P356

P1433

Molecular Pharmaceutics

P1476

Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF

@en

P2093

Donald Hnatowich

http://www.w3.org/2001/XMLSchema#string

Guozheng Liu

http://www.w3.org/2001/XMLSchema#string

Jiang He

http://www.w3.org/2001/XMLSchema#string

Shuping Dou

http://www.w3.org/2001/XMLSchema#string

Surong Zhang

http://www.w3.org/2001/XMLSchema#string

Xinrong Liu

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor

An improved method for covalently conjugating morpholino oligomers to antitumor antibodies

Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.

An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector

Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.

Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.

Development of a novel pretargeting system with bifunctional nucleic acid molecules.

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.

P304

1118-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP9002909

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44634723

http://www.w3.org/2001/XMLSchema#string

P698

20507096

http://www.w3.org/2001/XMLSchema#string

P932

2914689

http://www.w3.org/2001/XMLSchema#string